Holen Sie sich die Stockscreener-App
190.54
1.99%
3.71
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HUM?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$186.83
Offen:
$185.69
24-Stunden-Volumen:
2.35M
Relative Volume:
1.23
Marktkapitalisierung:
$22.92B
Einnahmen:
$126.36B
Nettoeinkommen (Verlust:
$1.30B
KGV:
17.86
EPS:
10.6697
Netto-Cashflow:
$1.55B
1W Leistung:
+0.37%
1M Leistung:
-8.36%
6M Leistung:
-35.90%
1J Leistung:
-27.12%
1-Tages-Spanne:
$184.06
$192.00
1-Wochen-Bereich:
$173.26
$192.00
52-Wochen-Spanne:
$169.61
$315.35
Humana Inc Stock (HUM) Company Profile
Firmenname
Humana Inc
Sektor
Branche
Telefon
(502) 580-1000
Adresse
101 E. MAIN STREET, LOUISVILLE, KY
Compare HUM vs UNH, CVS, CI, ELV
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
190.54 | 22.47B | 126.36B | 1.30B | 1.55B | 10.67 |
|
UNH
Unitedhealth Group Inc
|
293.27 | 259.67B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
79.90 | 99.25B | 402.11B | 1.73B | 7.81B | 1.3835 |
|
CI
Cigna Group
|
289.82 | 76.09B | 216.66B | 6.25B | 7.44B | 22.19 |
|
ELV
Elevance Health Inc
|
320.00 | 71.30B | 199.13B | 5.66B | 3.17B | 25.11 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-02-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2026-01-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-12-05 | Hochstufung | Jefferies | Hold → Buy |
| 2025-10-14 | Eingeleitet | Goldman | Sell |
| 2025-09-22 | Eingeleitet | Evercore ISI | In-line |
| 2025-05-01 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-11-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-10-07 | Herabstufung | Jefferies | Buy → Hold |
| 2024-10-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-10-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-10-02 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-10-02 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-02 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-06-24 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-03-22 | Eingeleitet | Raymond James | Mkt Perform |
| 2024-03-13 | Herabstufung | Argus | Buy → Hold |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-26 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-01-25 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-12 | Hochstufung | Argus | Hold → Buy |
| 2023-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-07-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-06-23 | Herabstufung | Argus | Buy → Hold |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-10-26 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-09-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2022-04-13 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-11-04 | Bestätigt | Barclays | Overweight |
| 2021-11-04 | Bestätigt | Credit Suisse | Outperform |
| 2021-11-04 | Bestätigt | Morgan Stanley | Overweight |
| 2021-11-04 | Bestätigt | Oppenheimer | Outperform |
| 2021-11-04 | Bestätigt | RBC Capital Mkts | Outperform |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-09-09 | Fortgesetzt | Barclays | Overweight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Neutral |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-01-04 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-10-02 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-16 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-06-05 | Eingeleitet | Goldman | Buy |
| 2020-01-03 | Bestätigt | JP Morgan | Overweight |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-09-30 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-04-23 | Eingeleitet | UBS | Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-12-20 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-08 | Bestätigt | BofA/Merrill | Buy |
| 2018-09-13 | Eingeleitet | Barclays | Overweight |
| 2018-07-12 | Fortgesetzt | Morgan Stanley | Overweight |
| 2018-07-06 | Bestätigt | Piper Jaffray | Overweight |
| 2018-06-01 | Fortgesetzt | Citigroup | Buy |
| 2018-02-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-02-08 | Bestätigt | Leerink Partners | Outperform |
| 2018-01-12 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Humana Inc Aktie (HUM) Neueste Nachrichten
The power of in-network care: quick facts across generations - Humana
UnitedHealth vs. Humana: Which Healthcare Stock Has More Upside Now? - InsuranceNewsNet
WA seniors scramble amid insurance dispute - The Seattle Times
Zacks Research Issues Positive Outlook for Humana Earnings - MarketBeat
Humana stock jumps 6% as Medicare Advantage enrollment report puts HUM back in focus - TechStock²
Artisan Partners Limited Partnership Sells 28,849 Shares of Humana Inc. $HUM - MarketBeat
Humana Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Barclays Lowers Humana (HUM) Price Target amid Questions on Margin Expansion Outlook - Finviz
RBC Capital Initiates Blackstone (BX) Coverage with $179 Target on Strong Growth Outlook - Finviz
Humana Tower in Louisville to be converted into Convention Hotel - Architectural Record
Humana Inc. stock outperforms competitors on strong trading day - MarketWatch
Humana Inc. to Present at the 2026 Leerink Partners Global Healthcare Conference - Yahoo Finance
Humana Inc (HUM) Trading 3.08% Higher on Feb 26 - GuruFocus
Has The Humana (HUM) Share Slump Opened Up A Valuation Opportunity Now - simplywall.st
FY2028 Earnings Estimate for Humana Issued By Zacks Research - MarketBeat
3 Reasons HUM Has Explosive Upside Potential - Finviz
For Joe Morales of Humana Group Benefits, relationships make the difference in San Antonio - The Business Journals
Humana (NYSE: HUM) SVP granted 5,669 shares, withholds stock for taxes - Stock Titan
Sanjay Shetty Acquires 810 Shares of Humana (NYSE:HUM) Stock - MarketBeat
Humana's CenterWell acquires Florida primary care networkLouisville Business First - The Business Journals
Insider Buying: Sanjay Shetty Acquires Shares of Humana Inc (HUM) - GuruFocus
Humana’s Shetty buys $150k in company stock - Investing.com
UBS reiterates Humana stock rating at Neutral with $195 target - Investing.com
UBS reiterates Humana stock rating at Neutral with $195 target By Investing.com - Investing.com UK
Barclays Lowers Humana (NYSE:HUM) Price Target to $176.00 - MarketBeat
Humana (HUM) Price Target Decreased by 18.51% to 237.71 - Nasdaq
Humana (BIT:1HUM) Price Target Decreased by 18.27% to 205.42 - Nasdaq
Former Humana executive named president of Geisinger Health Plan - Pottsville Republican Herald
Geisinger names Humana executive as president of health plan - Healthcare Finance News
Barclays Adjusts Humana Price Target to $176 From $245, Maintains Equal Weight Rating - marketscreener.com
Barclays cuts Humana stock price target on margin concerns to $176 - Investing.com India
How Investors May Respond To Humana (HUM) Weaker EPS And Affirmed Dividend In 2026 Outlook - simplywall.st
Why Affordability Must Be Our North Star - Humana
Humana Inc. (NYSE:HUM) Q4 2025 earnings call transcript - MSN
AMG National Trust Bank Buys 8,744 Shares of Humana Inc. $HUM - MarketBeat
This Week’s Leadership Moves: Travelodge, Accenture Federal, and Humana - CDO Magazine
RBC Capital downgrades Humana (HUM) - MSN
Alberta Investment Management Corp Takes Position in Humana Inc. $HUM - MarketBeat
Best Medicare Advantage Plans in 2026 - NerdWallet
Decoding Humana Inc (HUM): A Strategic SWOT Insight - GuruFocus
Humana Inc. (NYSE:HUM) to Issue $0.89 Quarterly Dividend - MarketBeat
HUMANA INC SEC 10-K Report - TradingView
Humana Stock’s 2026 EPS Guidance Came in Nearly $3 Below Analyst Estimates. Is it a Still Buy Today? - TIKR.com
Humana Invests $1.7 Million To Improve Health Outcomes Across Illinois - Pulse 2.0
Sonali Mathur, Humana Vice President of Data Strategy & Governance - CDO Magazine
Humana declares quarterly dividend of $0.885 per share - Investing.com
Humana Inc. Declares Quarterly Cash Dividend, Payable on April 24, 2026 - marketscreener.com
Pzena Investment Management LLC Decreases Stake in Humana Inc. $HUM - MarketBeat
Humana declares quarterly dividend of $0.885 per share By Investing.com - Investing.com UK
Humana Board Declares Payment of Quarterly Dividend to Stockholders - Business Wire
Vanguard Group Inc. Has $3.68 Billion Holdings in Humana Inc. $HUM - MarketBeat
Finanzdaten der Humana Inc-Aktie (HUM)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.54%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):